LEZ763

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LEZ763, covering 2020-12-17 to 2020-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 [Phase 1, Phase 2]